perylene has been researched along with Acute Promyelocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grant, S; Jarvis, WD; Povirk, LF; Traylor, RS; Turner, AJ | 1 |
Chang, SG; Jung, JC; Kim, JI; Lee, KT; Miyamoto, K; Park, HJ; Park, JH; Rho, YS | 1 |
2 other study(ies) available for perylene and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Anthracenes; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Cell Differentiation; Cell Line; Cyclic AMP-Dependent Protein Kinases; DNA Damage; DNA, Neoplasm; Enzyme Inhibitors; Gossypol; Humans; Isoquinolines; Leukemia, Promyelocytic, Acute; Naphthalenes; Perylene; Phenanthridines; Piperazines; Polycyclic Compounds; Protein Kinase C; Staurosporine; Time Factors; Tumor Cells, Cultured | 1994 |
Hypericin induces both differentiation and apoptosis in human promyelocytic leukemia HL-60 cells.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Cell Differentiation; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Perylene | 1999 |